Kiniksa Pharmaceuticals LtdNASDAQ:KNSA
- LAST PRICE24.1000
- TODAY'S CHANGE (%)-0.3500 (-1.4315%)
- Bid / Lots23.3100/ 1
- Ask / Lots25.1700/ 1
- Open / Previous Close24.4600 / 24.4500
- Day Range
- 52 Week Range
- Volume380,903
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KNSA |
|---|---|---|
| 09:32 ET | 1360 | 24.46 |
| 09:39 ET | 100 | 24.47 |
| 09:41 ET | 400 | 24.34 |
| 09:43 ET | 100 | 24.37 |
| 09:45 ET | 400 | 24.37 |
| 09:48 ET | 487 | 24.46 |
| 09:50 ET | 100 | 24.46 |
| 09:52 ET | 100 | 24.46 |
| 09:54 ET | 100 | 24.54 |
| 09:57 ET | 598 | 24.475 |
| 10:03 ET | 412 | 24.57 |
| 10:06 ET | 200 | 24.585 |
| 10:08 ET | 100 | 24.55 |
| 10:10 ET | 100 | 24.515 |
| 10:14 ET | 600 | 24.4625 |
| 10:15 ET | 100 | 24.395 |
| 10:21 ET | 1065 | 24.43 |
| 10:24 ET | 140500 | 24.36 |
| 10:26 ET | 100 | 24.415 |
| 10:28 ET | 100 | 24.415 |
| 10:30 ET | 100 | 24.46 |
| 10:32 ET | 1629 | 24.49 |
| 10:33 ET | 100 | 24.485 |
| 10:35 ET | 200 | 24.485 |
| 10:37 ET | 315 | 24.505 |
| 10:39 ET | 100 | 24.525 |
| 10:42 ET | 200 | 24.555 |
| 10:46 ET | 100 | 24.61 |
| 10:50 ET | 1500 | 24.6625 |
| 10:51 ET | 604 | 24.725 |
| 10:53 ET | 1400 | 24.645 |
| 10:55 ET | 500 | 24.615 |
| 11:00 ET | 400 | 24.605 |
| 11:02 ET | 428 | 24.605 |
| 11:04 ET | 600 | 24.585 |
| 11:06 ET | 1799 | 24.502 |
| 11:08 ET | 100 | 24.519 |
| 11:11 ET | 409 | 24.47 |
| 11:13 ET | 5921 | 24.385 |
| 11:15 ET | 100 | 24.43 |
| 11:20 ET | 100 | 24.36 |
| 11:22 ET | 427 | 24.3 |
| 11:24 ET | 1102 | 24.265 |
| 11:27 ET | 509 | 24.28 |
| 11:33 ET | 635 | 24.2798 |
| 11:36 ET | 300 | 24.22 |
| 11:38 ET | 617 | 24.305 |
| 11:42 ET | 100 | 24.3 |
| 11:47 ET | 300 | 24.275 |
| 11:51 ET | 660 | 24.27 |
| 11:54 ET | 600 | 24.22 |
| 11:56 ET | 100 | 24.22 |
| 11:58 ET | 988 | 24.285 |
| 12:00 ET | 100 | 24.27 |
| 12:02 ET | 100 | 24.27 |
| 12:07 ET | 400 | 24.19 |
| 12:09 ET | 1010 | 24.16 |
| 12:12 ET | 100 | 24.22 |
| 12:18 ET | 2900 | 24.39 |
| 12:20 ET | 200 | 24.315 |
| 12:23 ET | 100 | 24.3 |
| 12:30 ET | 100 | 24.28 |
| 12:39 ET | 500 | 24.32 |
| 12:41 ET | 400 | 24.27 |
| 12:50 ET | 100 | 24.27 |
| 12:54 ET | 300 | 24.24 |
| 12:56 ET | 700 | 24.27 |
| 12:57 ET | 582 | 24.305 |
| 12:59 ET | 100 | 24.32 |
| 01:01 ET | 700 | 24.37 |
| 01:08 ET | 645 | 24.36 |
| 01:10 ET | 100 | 24.34 |
| 01:14 ET | 100 | 24.34 |
| 01:21 ET | 300 | 24.25 |
| 01:24 ET | 2200 | 24.22 |
| 01:26 ET | 500 | 24.29 |
| 01:28 ET | 700 | 24.26 |
| 01:30 ET | 500 | 24.25 |
| 01:32 ET | 800 | 24.24 |
| 01:33 ET | 165 | 24.28 |
| 01:35 ET | 1626 | 24.26 |
| 01:37 ET | 804 | 24.29 |
| 01:39 ET | 500 | 24.33 |
| 01:42 ET | 600 | 24.29 |
| 01:44 ET | 500 | 24.3 |
| 01:46 ET | 500 | 24.29 |
| 01:48 ET | 875 | 24.24 |
| 01:50 ET | 500 | 24.21 |
| 01:53 ET | 200 | 24.24 |
| 01:55 ET | 200 | 24.25 |
| 01:57 ET | 600 | 24.25 |
| 02:02 ET | 200 | 24.21 |
| 02:04 ET | 300 | 24.18 |
| 02:06 ET | 293 | 24.1501 |
| 02:09 ET | 977 | 24.155 |
| 02:11 ET | 100 | 24.16 |
| 02:13 ET | 300 | 24.16 |
| 02:20 ET | 131 | 24.1301 |
| 02:22 ET | 700 | 24.135 |
| 02:24 ET | 1031 | 24.14 |
| 02:27 ET | 300 | 24.1 |
| 02:31 ET | 100 | 24.135 |
| 02:33 ET | 307 | 24.11 |
| 02:36 ET | 5087 | 24.12 |
| 02:38 ET | 200 | 24.1 |
| 02:42 ET | 384 | 24.11 |
| 02:44 ET | 300 | 24.08 |
| 02:45 ET | 2500 | 24.11 |
| 02:47 ET | 869 | 24.17 |
| 02:51 ET | 500 | 24.15 |
| 02:54 ET | 600 | 24.15 |
| 02:56 ET | 300 | 24.15 |
| 02:58 ET | 1136 | 24.175 |
| 03:00 ET | 100 | 24.17 |
| 03:02 ET | 1300 | 24.18 |
| 03:03 ET | 200 | 24.16 |
| 03:05 ET | 718 | 24.15 |
| 03:07 ET | 1500 | 24.14 |
| 03:09 ET | 507 | 24.205 |
| 03:14 ET | 100 | 24.205 |
| 03:16 ET | 300 | 24.235 |
| 03:18 ET | 300 | 24.22 |
| 03:21 ET | 700 | 24.21 |
| 03:23 ET | 100 | 24.19 |
| 03:25 ET | 700 | 24.16 |
| 03:27 ET | 600 | 24.165 |
| 03:34 ET | 1100 | 24.14 |
| 03:36 ET | 2538 | 24.18 |
| 03:38 ET | 724 | 24.17 |
| 03:39 ET | 200 | 24.16 |
| 03:41 ET | 4518 | 24.155 |
| 03:43 ET | 1500 | 24.19 |
| 03:45 ET | 1031 | 24.16 |
| 03:48 ET | 600 | 24.14 |
| 03:50 ET | 600 | 24.18 |
| 03:52 ET | 2020 | 24.19 |
| 03:54 ET | 2891 | 24.14 |
| 03:56 ET | 2672 | 24.16 |
| 03:57 ET | 1846 | 24.12 |
| 03:59 ET | 46829 | 24.1 |
Sep 13, 2024
DJ Kiniksa Pharmaceuticals Initiated at Buy by Jefferies, from 9:15AM ET on Friday Sep 13, 2024 by Dow Jones
9:15AM ET on Friday Sep 13, 2024 by Dow Jones
Aug 28, 2024
Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference, from 4:01PM ET on Wednesday Aug 28, 2024 by Dow Jones
4:01PM ET on Wednesday Aug 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kiniksa Pharmaceuticals Ltd | 1.7B | -134.8x | --- |
CareDx Inc | 1.5B | -9.6x | --- |
Zai Lab Ltd | 2.0B | -6.6x | --- |
MannKind Corp | 1.8B | 178.1x | --- |
Maravai LifeSciences Holdings Inc | 2.1B | -8.1x | --- |
BioCryst Pharmaceuticals Inc | 1.6B | -10.3x | --- |
Company Information
Kiniksa Pharmaceuticals, Ltd. is a biopharmaceutical company. The Company is focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its portfolio of immune-modulating assets, ARCALYST (rilonacept), KPL-404 and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. The Company’s ARCALYST is interleukin-1alpha (IL-1α), and interleukin-1beta (IL-1β), cytokine trap for the treatment of recurrent pericarditis and reduction in risk of recurrence in adults and children. Its KPL-404 is an investigational monoclonal antibody inhibitor of CD40-CD154 interaction. The Company’s Mavrilimumab is an investigational monoclonal antibody inhibitor targeting granulocyte-macrophage colony stimulating factor receptor alpha (GM-CSFRα).
Contact Information
- Headquarters
- Clarendon House, 2 Church StreetHAMILTON, Bermuda HM11
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Sanjiv Patel
- Chief Financial Officer, Senior Vice President
- Mark Ragosa
- Chief Operating Officer, Senior Vice President
- Eben Tessari
- Senior Vice President, Chief Commercial Officer
- Ross Moat
- Senior Vice President, Chief Medical Officer
- John Paolini
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.7B |
|---|---|
Revenue (TTM) | $338.9M |
Shares Outstanding | 71.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.32 |
EPS | $-0.18 |
Book Value | $6.23 |
P/E Ratio | -134.8x |
Price/Sales (TTM) | 5.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -8.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
